Diabetes mellitus and peripheral organs involvement: Current treatment options

Abstract

Diabetes mellitus is a chronic and multi-systemic disease with various treatment options and has long-term effect on lifestyle of individuals and society. Not only disesase itself but also damage to peripherical organs as a result of disease in long term is an important cause of morbidity and mortality. In this review study it has been aimed to assess complications caused by peripherical organ involvment and treatment options rather than those caused by diabetes mellitus itself. J Clin Exp Invest 2014; 5 (2): 329-335

Keywords

• Diabetes mellitus, peripheral involvement, treatment options

Diyabetes mellitüs ve periferik organ tutulumu: Güncel tedavi seçenekleri

Öz

Diyabetes mellitüs bireylerin ve toplumların uzun süreli yaşam şekline etki eden kronik, multi-sistemik ve tedavi seçenekleri çeşitlilik gösteren bir hastalıktır. Hastalığın kendisinin vücutta yaptığı değişimler kadar uzun dönemde periferik organlarda oluşturduğu hasarlar sonucu önemli morbidite ve mortalite nedenidir. Bu derlemede Diyabetes mellitüs kendisinin direkt yaptığı dahili hastalıktan ziyade periferik organ tutulumu sonucu gelişen komplikasyonları ve tedavi seçeneklerini literatür eşliğinde değerlendirmeyi amaçladık.

Anahtar Kelimeler

• Diyabetes mellitüs, periferik tutulum, tedavi seçenekleri

References

1. Kurup H, Thomas M. Orthopaedics and diabetes. Acta Orthop Belg 2013;79:483-487.
2. Gupta SK, Singh SK. Diabetic foot: A continuing chal- lenge. Adv Exp Med Biol 2012; 771:123-138.
3. Litzelman DK, Marriott DJ, Vinicor F. Independent physiological predictors of foot lesions in patients with NIDDM. Diabetes Care 1997;20:1273-1278.
4. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005;293:217- 228.
5. Bruhn-Olszewska B, Korzon-Burakowska A, Gabig- Cimińska M, et al. Molecular factors involved in the development of diabetic foot syndrome. Acta Biochim Pol 2012;59:507-513.
6. Rota E, Quadri R, Fanti E, et al. Electrophysiological findings of peripheral neuropathy in newly diagnosed type II diabetes mellitus. Journal of the Peripheral Nervous System 2005;10:348-353.
7. Özge A, Saraçoglu M, Gürtekin Y, et al. The sensitivity of sympathetic skin responses and standart electro- physiological methods in diagnosis of diabetic neu- ropathy. Electromyogr Clin Neurophysiol 2000;40:37- 43.
8. Reiber GE, Vileikyte L, Boyko EJ, et al. Causal path- ways for incident lower extremity ulcers in patients with diabetes from two settings. Diabetes Care 1999;22:157-162.

9. Pham H, Armstrong DG, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration. A prospective multicenter trial. Diabe- tes Care 2000;23:606-611.
10. Crawford F, Inkster M, Kleijnen J, et al. Predicting foot ulcers in patients with diabetes: a systematic review and meta-analysis. QJM 2007;100:65-86.
11. Woo KY, Santos V, Gamba M. Understanding diabetic foot ulcers. Nursing 2013;43:36-42.
12. Pham H, Armstrong DG, Harvey C, et al. Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabe- tes Care 2000;23:606-611.
13. Vileikyte L. Psyhlogical aspects of diabetic peripheral neuropathy. Diabetes Rev 1999;7:387-396.
14. Morona JK, Buckley ES, Jones S, et al. Comparison of the clinical effectiveness of different off-loading de- vices for the treatment of neuropathic foot ulcers in patients with diabetes: a systematic review and meta- analysis. Diabetes Metab Res Rev 2013;29:183-193.
15. Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of two diabetic foot ulcer classification systems: the Wagner and the University of Texas wound classifica- tion systems. Diabetes Care 2001;24:84-88.
16. Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Guidelines for Diabetic Foot Infections. Clin Infect Dis 2004;39: 885-910.
17. Edmonds M, Foster A, Pod DM. The use of antibiotics in the diabetic foot. Am J Surg 2004;187:25-28.
18. Ansari MA, Shukla VK. Foot Infections. Lower extrem- ity wounds 2005;4:74-87.
19. Hatipoglu M, Mutluoglu M, Uzun G, et al. The micro- biologic profile of diabetic foot infections in Turkey: a 20-year systematic review: Diabetic foot infections in Turkey. Eur J Clin Microbiol Infect Dis 2014;33:871- 878.
20. Nelson EA, O’Meara S, Golder S, et al. Systematic review of antimicrobial treatments for diabetic foot ul- cers. Diabetic Medicine 2006;23:348-359.
21. Armstrong DG, Lipsky BA. Advances in the treatment of diabetic foot infections. Diyabetes Technology and Therapeutics 2004;6:167-177.
22. van Baal JG. Surgical Treatment of the diabetic foot. Clin Infect Dis 2004;39:123-128.
23. Löndahl M. Hyperbaric oxygen therapy as adjunctive treatment of diabetic foot ulcers. Med Clin North Am 2013;97:957-980.
24. Lipsky BA. Medical treatment of Diabetic foot Infec- tions. Clin Infect Dis 2004; 39: 104-114.
25. Cruciani M, Lipsky BA, Mengoli C, et al. Are granu- locyte colony stimulating factors beneficial in treating diabetic foot infections? Diyabetes Care 2005;28:454- 460.
26. Hilton JR, Williams DT, Beuker B, et al. Wound dress- ings in diabetic foot disease. Clin Infect Dis 2004; 39:100-103.
27. Jones SM, Bonwell PE, Shakepeare PG. Advances in wound healing: topical negative pressure therapy. Postgrad Med J 2005; 81:353-357.
28. Karatoprak K, Uysal S, Akkılık ZS, et al. Diyabette glisemik kontrolün serum biyokimyasal parametreleri ile ilişkisi. Abant Med J 2012;1:51-54.
29. Ricco JB, Thanh Phong L, Schneider F, et al. The dia- betic foot: a review. J Cardiovasc Surg 2013;54:755- 762.
30. Caravaggi C, Ferraresi R, Bassetti M, et al. Manage- ment of ischemic diabetic foot. J Cardiovasc Surg 2013;54:737-754.
31. Caravaggi C, Sganzaroli A, Galenda P, et al. The management of the infected diabetic foot. Curr Diabe- tes Rev 2013;1;9:7-24.
32. Tanrıverdi MH, Çelepkolu T, Aslanhan H. Diabetes mellitus and primary healthcare. J Clin Exp Invest 2013;4:562-567.